Anzeige
Mehr »
Login
Montag, 04.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Sagenhafte +10.000 % Gewinnchance mit Spezialisten für KI-Cybersecurity!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
344 Leser
Artikel bewerten:
(1)

Center for Active Design Launches Fitwel Viral Response Module

Boston Properties, BentallGreenOak, Brookfield Properties, DLC Europe, Hudson Pacific Properties, Kilroy Realty Corporation, Nuveen Real Estate, and The Tower Companies are latest to commit to Fitwel certification of evidence-based viral mitigation policies.

NEW YORK, Sept. 16, 2020 /PRNewswire/ -- Fitwel, the healthy building certification system operated by The Center for Active Design (CfAD), today announced the formal launch of its Viral Response module, with additional commitments for adoption from leading companies, including BentallGreenOak, Boston Properties, Brookfield Properties, DLC Europe, Hudson Pacific Properties, Kilroy Realty Corporation, Nuveen Real Estate, and The Tower Companies.

FITWEL & Design is a registered trademark of the U.S. Department of Health & Human Services (HHS). Participation by The Center for Active Design and/or any other organization does not imply endorsement by HHS.

Today's formal launch of the module, which provides annual, third-party certification of policies and practices informed by the latest public health research on mitigating the spread of contagious diseases, reflects the quick progress Fitwel and its industry and academic advisors have made to prepare the module for widespread implementation. The module's comprehensive guidance and turnkey policies were designed to be efficiently implemented across commercial and residential portfolios or individual assets, helping companies to build trust with tenants and employees.

Unlike other products, Fitwel's Viral Response module requires that companies follow a set of baseline strategies - actions that are necessary to mitigate the spread of infectious respiratory diseases such as COVID-19. These minimum requirements cover indoor environments, behavioral change, and building occupant trust, and get as granular as specifying the chemicals that are needed in cleaning products. Fitwel and its advisors intend to update the module annually in accordance with the evolving science.

Joanna Frank, President and CEO of CfAD, said, "Fitwel was initially created to optimize built environments for chronic disease prevention. Companies can chart their own course within Fitwel Certification to address these long-term issues without minimum requirements. However, infectious disease mitigation is quite different, and the science shows there are baseline requirements that companies absolutely must follow to effectively reduce infectious respiratory disease transmission in buildings. The Viral Response module was developed to set the industry standard in response to COVID-19, and it represents an evolution of Fitwel's efforts to promote health and wellness in the built environment."

Fitwel's two-step certification process enables companies the flexibility to establish and implement viral response policies at scale. Users establish policies to cover any portfolio, selection of assets or individual tenant spaces that have consistent operational practices, then submit to have these policies certified by CfAD in a six-week, double-blind review process. Once Viral Response certification is achieved, companies can demonstrate application within specific assets. This step verifies that the strategies have been put into practice, and CfAD recognizes this achievement with a plaque that companies can use to convey to occupants that their spaces are optimized for viral mitigation.

"The built environment plays a crucial role in the health, wellness, and productivity of the people who live and work within the communities that we manage on behalf of our clients. BentallGreenOak's role as industry advisor and early adopter of the Center for Active Design's Fitwel Viral Response module provides us with an industry leading response to COVID-19 to better serve our tenants and community stakeholders, while equipping our property management teams with clear and informed guidance for implementation across our managed portfolio," said Anna Murray, Managing Director, Global Head of ESG, BentallGreenOak.

BentallGreenOak, Harrison Street, QuadReal Property Group, Tishman Speyer, Triovest Realty Advisors, and Vornado Realty Trust are among the companies that served as the industry advisors that prototyped the module. A group of highly respected public health experts from leading institutions such as Columbia University Irving Medical Center, Icahn School of Medicine at Mount Sinai, and Queensland University of Technology served on the module's academic advisory board and advised on its strategies.

About Fitwel and the Center for Active Design
Fitwel is the world's leading certification system committed to building health for all. Generated by expert analysis of 5,600+ academic research studies, Fitwel is implementing a vision for a healthier future where all buildings and communities are enhanced to strengthen health and well-being. Fitwel was originally created by the U.S. Centers for Disease Control (CDC) and Prevention and U.S. General Services Administration. The CDC remains the research and evaluation partner for Fitwel. The Center for Active Design, a global not-for-profit organization, was selected as the licensed operator of Fitwel, charged with expanding Fitwel to the global market. To learn more about Fitwel, please visit: www.fitwel.org.

Logo - https://mma.prnewswire.com/media/1080221/CAD_Logo_Blue_Logo.jpg

© 2020 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.